In February 2021, the Research Team at DGT opened a trial on LOCI: Letrozole or Clomifene, with or without metformin, for ovulation induction in women with polycystic ovary syndrome. The research trial investigates the clinical and cost-effectiveness.
The great news is that DGT has now been ranked number 1 in the top 39 recruiting sites across UK for the trial and has also had its first successful pregnancy after just one cycle. It’s the joint work of our fertility team together with the research team that achieved these wonderful results.
Our fertility team thrives to provide high-standard care to our patients and participation in such research would help find the evidence of managing patients with polycystic ovary syndrome. Well done to everyone involved!